We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
The FDA and Brigham and Women’s Hospital are expanding a demonstration project with Aetion to use real-world evidence (RWE) to predict the results of seven ongoing Phase IV trials.